CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,197,943 | +21.4% | 957,951 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $5,104,453 | +78.2% | 824,629 | +10.9% | 0.00% | – |
| Q1 2023 | $2,864,043 | +193.2% | 743,907 | +136.1% | 0.00% | – |
| Q4 2022 | $976,919 | +1358.1% | 315,135 | +1810.6% | 0.00% | – |
| Q3 2022 | $67,000 | -65.8% | 16,494 | -59.0% | 0.00% | – |
| Q2 2022 | $196,000 | +1.0% | 40,264 | +86.3% | 0.00% | – |
| Q1 2022 | $194,000 | +22.8% | 21,612 | +53.4% | 0.00% | – |
| Q4 2021 | $158,000 | +23.4% | 14,085 | +84.6% | 0.00% | – |
| Q3 2021 | $128,000 | – | 7,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |